Carl Gustav Carus University Hospital, Dresden – Germany
About Prof. Dr. med. Johannes Huber
Prof. Dr. med. Johannes Huber, FEBU, MHBA, is a Senior Consultant Urologist with over 21 years of experience in uro-oncology, robotic and minimally invasive prostate surgery, and patient-centred care. He is an internationally recognised expert in prostate cancer, renal cell carcinoma and shared decision-making, and has authored more than 170 peer-reviewed articles.
- 21+ years of clinical experience in urology and uro-oncology
- Fellow of the European Board of Urology (FEBU); Master of Health Business Administration (MHBA)
- Author of 170+ peer-reviewed publications; cited 3,499+ times
- Internationally recognised researcher in prostate and kidney cancer
- Pioneer in shared decision-making and digital patient-reported outcomes
Qualifications & Credentials
Medical Degrees
- Medical Graduation, Heidelberg University, Germany
- Doctor of Medicine (Dr. med.), Heidelberg University, Germany
- Doctor of Philosophy (PhD)
- Master of Health Business Administration (MHBA), Friedrich Alexander University Erlangen-Nuremberg, 2015–2017
Fellowships & Special Training
- Postdoctoral Researcher, Institute for Biomedical Ethics, University of Zurich, Switzerland, 2011–2012
- Fellow of the European Board of Urology (FEBU)
- Specialty Training in Urology & Uro-Oncology, Germany
Certifications & Accreditations
- Saxon State Chamber of Physicians (Sächsische Landesärztekammer) Registration
- German Society of Urology (DGU) – Member
- European Association of Urology (EAU) – Member
- European Board of Urology (FEBU) – Fellow
Areas of Expertise
Major Conditions Treated
- Prostate Cancer
- Bladder Cancer
- Renal Cell Carcinoma (Kidney Cancer)
- Testicular Cancer
- Benign Prostatic Hyperplasia (BPH)
- Microscopic & Macroscopic Hematuria
- Urinary Tract Infections (UTI)
- Erectile Dysfunction
- Male Infertility
- Kidney Stones
- Penile Cancer
- Urinary Incontinence
Sub-specialties
- Uro-Oncology & Prostate Cancer: Multiparametric MRI-guided prostate biopsy, robotic prostatectomy and active surveillance — making him a sought-after specialist for international patients searching for the best urology doctor in Germany.
- Robotic & Minimally Invasive Urology: Robot-assisted radical prostatectomy, partial nephrectomy and reconstructive urological surgery.
- Patient-Centred Care & Shared Decision-Making: Internationally cited researcher in patient-reported outcomes, prehabilitation and digital health.
Advanced Procedures & Treatments
- Robot-Assisted Radical Prostatectomy
- Robot-Assisted Partial Nephrectomy
- Multiparametric MRI / MRI-Targeted Prostate Biopsy
- Transurethral Resection of the Prostate (TURP)
- Holmium Laser Enucleation of the Prostate (HoLEP)
- Cystectomy & Urinary Diversion (Bladder Cancer)
- Adjuvant Pembrolizumab & Targeted Therapy for Renal Cell Carcinoma
- Active Surveillance Programmes for Low-Risk Prostate Cancer
- Prehabilitation Protocols Before Major Urological Surgery
List of Disease and Treatment for which Prof. Dr. med. Johannes Huber can be consulted
Professional Experience
Current Affiliation
- Carl Gustav Carus University Hospital, Dresden, Germany — Senior Consultant Urologist, Department of Urology, Present
Past Affiliations
- University Hospital Marburg, Germany — Director, Department of Urology, 2021–2024
- Carl Gustav Carus University Hospital, Dresden — Senior Physician, Deputy Director and Clinic Director, Department of Urology, 2013–2021
- University of Zurich, Switzerland — Postdoctoral Researcher, Institute for Biomedical Ethics, 2011–2012
- Heidelberg University Hospital, Germany — Resident and Specialist, Department of Urology
Academic & Research Roles
- W3 Professor of Urology (academic chair held in his career)
- Researcher in patient-centred care, prostate cancer outcomes and digital health
- Reviewer for major international urology journals
Key Achievements
- 21+ years of urological practice across leading German university hospitals
- 170+ peer-reviewed publications; 3,499+ scholarly citations
- Internationally recognised expert in prostate and renal cell carcinoma
- Pioneer of shared decision-making and prehabilitation in urology
Awards & Recognitions
National & International Awards
- Fellow of the European Board of Urology (FEBU)
- Recognised researcher cited 3,499+ times on Google Scholar
Professional Memberships
- German Society of Urology (DGU)
- European Association of Urology (EAU)
- European Board of Urology (FEBU)
Research & Publications
Published Papers (Selected)
- Huber J, et al. Adjuvant therapy with pembrolizumab in renal cell carcinoma: real-world experiences from a retrospective, multi-institutional cohort.
- Huber J, et al. Multiparametric MRI (mpMRI) and targeted biopsy of the prostate enhance the tumor detection rate.
- Huber J, et al. Patient-centred care and shared decision-making in urology — published across multiple international peer-reviewed journals.
- 170+ additional peer-reviewed publications in journals including European Urology, Journal of Urology and BJU International.
Ongoing Research & Clinical Interests
- Prostate cancer treatment outcomes and active surveillance
- Renal cell carcinoma and adjuvant immunotherapy
- Patient-reported outcomes and shared decision-making
- Prehabilitation and digital health in urology
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Urology Consultation | ₹12,000 – ₹25,000 | $150 – $300 |
| Multiparametric MRI Prostate Biopsy | ₹2,50,000 – ₹6,00,000 | $3,000 – $7,200 |
| Robot-Assisted Radical Prostatectomy | ₹15,00,000 – ₹30,00,000 | $18,000 – $36,000 |
| Robot-Assisted Partial Nephrectomy | ₹15,00,000 – ₹28,00,000 | $18,000 – $33,600 |
| HoLEP / Laser Prostate Surgery | ₹6,00,000 – ₹12,00,000 | $7,200 – $14,400 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. med. Johannes Huber use in Urologist treatment?
Prof. Huber uses cutting-edge technologies including robot-assisted radical prostatectomy and partial nephrectomy, multiparametric MRI-targeted prostate biopsy, holmium laser prostate surgery, prehabilitation protocols and digital patient-reported outcome platforms.
2. What conditions does Prof. Dr. med. Johannes Huber specialize in treating?
He specialises in prostate cancer, bladder cancer, renal cell carcinoma, testicular cancer, BPH, hematuria, erectile dysfunction, male infertility, kidney stones and urinary incontinence — making him a leading uro-oncology specialist in Dresden, Germany.
3. How do I book an appointment with Prof. Dr. med. Johannes Huber?
Appointments with Prof. Dr. med. Johannes Huber can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. med. Johannes Huber?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Johannes Huber, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. med. Johannes Huber offer second opinions for Urologist cases?
Yes. Second opinion consultations with Prof. Huber can be arranged via Cancer Rounds for patients seeking expert review of prostate, kidney or bladder cancer cases from an internationally recognised Urologist specialist in Dresden, Germany.
Carl Gustav Carus University Hospital, Dresden - Germany
